Expression of SIRT3 was reported to be significantly associated with poor prognosis in cancers such as breast cancer [8], colon cancer [9], and esophageal cancer [10]; but opposite results were reported in hepatocellular carcinoma [11, 12] and gastric cancer [13, 14]. The gene discussed is SIRT3; the disease is breast carcinoma.